Researchers at Binghamton University, State University of New York have devised a new way to protect personal electronic health records using a patient’s own heartbeat.

For the first time, researchers have developed tests that could improve treatment for heart failure patients by diagnosing the condition with greater accuracy and detecting the onset of congestive heart failure earlier. The findings were published in the Cardiovascular Disease issue of Clinical Chemistry, the journal of the American Association for Clinical Chemistry (AACC).

The ultrasound systems space, which covers 39 major markets, is set to rise steadily from $4.2 billion in 2016 to $5 billion by 2023, according to research and consulting firm GlobalData. This represents a compound annual growth rate (CAGR) of 2.5 percent. The company’s latest report states that the growth will primarily be driven by the rising prevalence of diseases and expanding demand for cost-effective quality healthcare.

People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a stent, the artery is much more likely to clog up again. However, researchers at Joslin Diabetes Centers, Boston, now have uncovered an explanation for why these procedures often fail, which may lead toward better alternatives.

CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the universal balloon design of the HeartLight Endoscopic Ablation System and introduces an advanced feature set that optimizes the speed and magnitude of target tissue contact during pulmonary vein isolation (PVI) procedures.

Edwards Lifesciences Corp. announced that it has closed its acquisition of Valtech Cardio Ltd., developer of the Cardioband System for transcatheter repair of the mitral and tricuspid valves.  Edwards announced in November that it had signed an agreement to acquire Valtech.

Survival statistics, surgeon-specific experience and complication rates are the types of information most wanted by parents of children with congenital heart disease, according to a survey released at the 53rd Annual Meeting of The Society of Thoracic Surgeons (STS).

Elderly patients with aortic stenosis (AS) and medium surgical risk experienced better than expected results after undergoing traditional surgical aortic valve replacement (SAVR), according to research presented at the 53rd Annual Meeting of The Society of Thoracic Surgeons.

Subscribe Now